Showing results (11-20 of 41) with videos related to
Sort By:
Pageof 5
Journal of Thyroid Research|November 5, 2010
Old and new insights in the treatment of thyroid carcinomaJoan Manel Gasent Blesa, Enrique Grande Pulido, Mariano Provencio Pulla, et al.Tumori|February 24, 2015
High-dose chemotherapy followed by autologous and allogeneic hematopoietic stem cell transplantation in patients with follicular non-Hodgkin’s lymphoma in the rituximab eraIgnacio García Escobar, Blanca Cantos Sánchez de Ibarguen, Virginia Calvo de Juan, et al.Clinical & Developmental Immunology|August 29, 2012
Role of immune escape mechanisms in Hodgkin's lymphoma development and progression: a whole new world with therapeutic implicationsLuis de la Cruz-Merino, Marylène Lejeune, Esteban Nogales Fernández, et al.Therapeutic Advances in Medical Oncology|May 25, 2026
TROPION-Lung14 study protocol: a phase III study of osimertinib in combination with datopotamab deruxtecan versus osimertinib alone as first-line treatment for patients with EGFR-mutated locally advanced or metastatic non-small cell lung cancerShun Lu, Mariano Provencio Pulla, Eldsamira Mascarenhas, et al.Journal of Gastrointestinal Cancer|February 29, 2012
Phase II trial of concomitant neoadjuvant chemotherapy with oxaliplatin and capecitabine and intensity-modulated radiotherapy (IMRT) in rectal cancerJoan Manel Gasent Blesa, Javier Garde Noguera, Juan Bautista Laforga Canales, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 6, 2024
Identification of non-actionable mutations with prognostic and predictive value in patients with advanced or metastatic non-small cell lung cancerMariano Provencio-Pulla, Diego Pérez-Parente, Sara Olson, et al.Investigational New Drugs|August 3, 2024
A phase I safety and efficacy clinical trial of plocabulin and gemcitabine in patients with advanced solid tumorsMohammad H Ghalib, Mariano Provencio Pulla, Maria J De Miguel Luken, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 13, 2026
Management of borderline resectable NSCLC: a narrative reviewXabier Mielgo-Rubio, Samantha Aso González, Eider Azkona Uribelarrea, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 2, 2023
Sexual dysfunction in patients with cancer, a challenge in oncology practice: results of the CLARIFY projectAylen Vanessa Ospina-Serrano, Constanza Maximiano, Blanca Cantos, et al.Case Reports in Oncology|January 24, 2013
Durable complete remission of a brainstem glioma treated with a combination of bevacizumab and cetuximabJoan Manel Gasent Blesa, Sara Blasco Mollá, María Fonfría Esparcia, et al.Pageof 5